SMC021A - absorption, efficacy and tolerance in patients with osteoarthritis. A placebo-controlled 14-days study.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Calcitonin (Primary) ; Calcitonin (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Sponsors Nordic Bioscience
- 06 Jul 2007 New trial record.